platinum has been researched along with Colorectal Cancer in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 6 (17.65) | 29.6817 |
| 2010's | 11 (32.35) | 24.3611 |
| 2020's | 15 (44.12) | 2.80 |
| Authors | Studies |
|---|---|
| Brabec, V; Hoeschele, J; Kasparkova, J; Kostrhunova, H; Markova, L; Novohradsky, V | 1 |
| Boerma, D; Constantinides, A; de Hingh, IHJT; Elias, SG; Huitema, ADR; Koster, J; Kranenburg, O; Laoukili, J; Nienhuijs, SW; Raats, DAE; Rinkes, IHMB; van Grevenstein, HMU; van Schelven, SJ; van Wettum, J; Volckmann, R; Wassenaar, ECE; Wiezer, RJ | 1 |
| Martens, JWM; Smid, M; Wilting, SM | 1 |
| Goto, A; Higashi, T; Imai, K; Inoue, K; Iwasaki, M; Kanehara, R; Katanoda, K; Kobayashi, S; Noda, M; Ohashi, K; Saito, E; Taguri, M; Watanabe, T | 1 |
| Bartoletti, M; Canzonieri, V; Clemente, N; Corsetti, S; Fornasarig, M; Giorda, G; Lucia, E; Nicoloso, MS; Palazzari, E; Pivetta, T; Puglisi, F; Scalone, S; Segatto, E; Sorio, R; Viel, A; Zdjelar, A | 1 |
| Aderibigbe, BA; Alven, S; Buyana, B; Naki, T | 1 |
| Chen, Y; Li, B; Li, X; Li, Z; Liu, Y; Meng, Q; Sun, Z; Zhou, H | 1 |
| Alexandre, J; Brachet, PE; Colomba, E; Coquard, IR; Coupez, D; de Percin, S; Delanoy, N; Fabbro, M; Frenel, JS; Genestie, C; Joly, F; Le Teuff, G; Leary, A; Pautier, P; Sajous, C | 1 |
| Hao, Y; Li, R; Min, Y; Pan, W; Tian, S | 1 |
| Chen, SX; Jiang, HQ; Jiang, XY; Jin, XX; Liu, HQ; Liu, SM; Liu, T; Tian, H; Wang, SL; Wang, YJ; Xie, XL; Zhang, JN; Zhou, X | 1 |
| Cao, Y; Chang, Q; Chen, EX; Hedley, D; Ornatsky, O; Zhang, W | 1 |
| Badia, J; Balcells, C; Baldomà, L; Cascante, M; Crespo, M; Font-Bardia, M; Lázaro, A; Quirante, J; Rissanen, K; Rodríguez, L; Ward, JS | 1 |
| Arena, S; Bardelli, A; Mauri, G; Sartore-Bianchi, A; Siena, S | 1 |
| Cui, Y; Gao, Q; Li, Y; Liu, S; Sun, Z; Wang, X; Zhang, H; Zhang, S | 1 |
| Beijnen, JH; Bisseling, TM; de Wit, R; Kerst, M; Lansdorp-Vogelaar, I; Meijer, GA; Moons, LMG; Mulder, SF; Saveur, L; Snaebjornsson, P; Spaander, MCW; van der Biessen-van Beek, D; van Leerdam, ME; van Leeuwen, FE; Ykema, BLM; Zweers, D | 1 |
| Devocelle, M; Griffith, DM; McKeon, AM; Murphy, BM; Noonan, J | 1 |
| Lin, CY; Peng, CL; Shieh, MJ; Yang, SJ | 1 |
| Lans, H; Ribeiro-Silva, C; Sabatella, M; Slyskova, J; Stok, C; Theil, AF; Vermeulen, W | 1 |
| Atkinson, CJ; Győrffy, B; Ham, S; Kawamata, F; Liu, C; Möller, A; Munn, AL; Wei, MQ; Whitehall, V; Wiegmans, AP | 1 |
| Eslami Moghadam, M; Hosseinzadeh, S; Shahvelayati, AS; Sheshmani, S | 1 |
| Adam, F; Al-Juaid, S; Al-Suede, FSR; Arafath, MA; Khadeer Ahamed, MB; Majid, AMSA | 1 |
| Kotb, R; Paquette, B; Sanche, L; Tippayamontri, T | 1 |
| Ford, JM; McPherson, LA; Shen, Y | 1 |
| Gabano, E; Gandin, V; Marzano, C; Osella, D; Pelosi, G; Ravera, M | 1 |
| Gao, Q; Gao, X; Li, T; Shi, Y; Yang, L | 1 |
| Ang, WH; Chin, CF; Ho, HK; Hong Thng, AH; Pang, YY; Yap, SQ | 1 |
| Au-Yeung, SC; Ho, YP; Li, KK; Pang, SK; Yu, CW | 1 |
| Cho, HK; Chung, SJ; Kang, JH; Kim, DD; Kuh, HJ; Lee, ES; Lee, JW; Lee, KS; Park, JK; Shim, CK | 1 |
| Boku, N; Gotoh, M; Matsumura, Y; Muro, K; Mutoh, M; Nagashima, F; Ohtsu, A; Sano, Y; Shirao, K; Tanigawara, Y; Yamada, Y | 1 |
| Au-Yeung, SC; Ho, YP; Pang, SK; Yu, CW | 1 |
| Allain, P; Boisdron-Celle, M; Brienza, S; Cailleux, A; Cvitkovic, E; Gamelin, E; Krikorian, A; Larra, F; Lebouil, A; Robert, J; Turcant, A | 1 |
| Allain, P; Boisdron-Celle, M; Bouil, AL; Brienza, S; Cailleux, A; Cvitkovic, E; Delva, R; Gamelin, E; Krikorian, A; Larra, F; Robert, J; Turcant, A | 1 |
| Christen, RD; Howell, SB; Kondo, A; Lin, X; Mishima, M; Ramamurthi, K | 1 |
| Bedenne, L; Cercueil, JP; Chauffert, B; Correia, M; Coudert, B; Fargeot, P; Flesch, M; Isambert, N; Krause, D; Osmak, L; Zanetta, S | 1 |
2 review(s) available for platinum and Colorectal Cancer
| Article | Year |
|---|---|
Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Colorectal Neoplasms; Female; Humans; Male; Nanoparticles; Organoplatinum Compounds; Oxaliplatin; Platinum | 2022 |
The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer.
Topics: Colonic Neoplasms; Colorectal Neoplasms; DNA Damage; Humans; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2020 |
5 trial(s) available for platinum and Colorectal Cancer
| Article | Year |
|---|---|
Clinical pharmacokinetics of oxaliplatin and 5-fluorouracil administered in combination with leucovorin in Korean patients with advanced colorectal cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Creatinine; Female; Fluorouracil; Humans; Korea; Leucovorin; Male; Metabolic Clearance Rate; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Platinum | 2006 |
Phase I study of single-dose oxaliplatin in Japanese patients with malignant tumors.
Topics: Adult; Anorexia; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum | 2006 |
Determination of unbound platinum after oxaliplatin administration: comparison of currently available methods and influence of various parameters.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Leucovorin; Organoplatinum Compounds; Oxaliplatin; Platinum; Regression Analysis | 1998 |
Cumulative pharmacokinetic study of oxaliplatin, administered every three weeks, combined with 5-fluorouracil in colorectal cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Administration Schedule; Fluorouracil; Half-Life; Humans; Infusions, Intravenous; Leucovorin; Mass Spectrometry; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Platinum; Regression Analysis; Sensitivity and Specificity | 1997 |
Hepatic arterial infusion of cisplatin diluted in hypotonic 25 g/l glucose solution administered in balloon-occluded hepatic artery: experimental rationale and clinical pilot study.
Topics: Adult; Aged; Antineoplastic Agents; Balloon Occlusion; Breast Neoplasms; Cell Survival; Cisplatin; Colorectal Neoplasms; Female; Glucose; Hepatic Artery; Humans; Hypotonic Solutions; Infusions, Intra-Arterial; Liver Neoplasms; Middle Aged; Pilot Projects; Platinum; Tumor Cells, Cultured | 2001 |
27 other study(ies) available for platinum and Colorectal Cancer
| Article | Year |
|---|---|
A [Pt(cis-1,3-diaminocycloalkane)Cl
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colorectal Neoplasms; Coordination Complexes; Immunomodulating Agents; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Platinum | 2022 |
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity.
Topics: Colorectal Neoplasms; Humans; Oxaliplatin; Peritoneal Neoplasms; Peritoneum; Platinum | 2022 |
Lost by Transcription: Fork Failures, Elevated Expression, and Clinical Consequences Related to Deletions in Metastatic Colorectal Cancer.
Topics: Chromosome Fragile Sites; Colorectal Neoplasms; DNA Replication; Humans; Platinum; Replication Origin | 2022 |
Association between diabetes and adjuvant chemotherapy implementation in patients with stage III colorectal cancer.
Topics: Aged; Chemotherapy, Adjuvant; Colorectal Neoplasms; Diabetes Mellitus; Female; Humans; Male; Platinum; Postoperative Complications; Prognosis; Retrospective Studies | 2022 |
An Exceptional Response to Dostarlimab in Mismatch Repair Deficient, Microsatellite Instability-High and Platinum Refractory Endometrial Cancer.
Topics: Antibodies, Monoclonal, Humanized; Brain Neoplasms; Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplastic Syndromes, Hereditary; Platinum; Programmed Cell Death 1 Receptor | 2022 |
Supramolecular Combination Chemotherapy: Cucurbit[8]uril Complex Enhanced Platinum Drug Infiltration and Modified Nanomechanical Property of Colorectal Cancer Cells.
Topics: Bridged-Ring Compounds; Colorectal Neoplasms; Humans; Imidazoles; Platinum | 2022 |
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Topics: Colorectal Neoplasms; DNA Mismatch Repair; Endometrial Neoplasms; Female; Humans; Microsatellite Instability; Platinum; Retrospective Studies | 2023 |
Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy.
Topics: Animals; Colorectal Neoplasms; Disease Models, Animal; Immunomodulation; Immunotherapy; Mice; Platinum; Tumor Microenvironment | 2023 |
Prostaglandin F
Topics: Cell Line, Tumor; Colorectal Neoplasms; DNA Adducts; Drug Resistance, Neoplasm; Humans; Oxaliplatin; Platinum; Prostaglandins; Reactive Oxygen Species; RNA, Messenger | 2023 |
Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Colorectal Neoplasms; Female; Fluorouracil; Heavy Metal Poisoning, Nervous System; Humans; Leucovorin; Limit of Detection; Male; Mass Spectrometry; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Platinum; Skin | 2019 |
Luminescent Pt
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colorectal Neoplasms; Coordination Complexes; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Male; Molecular Conformation; Platinum; Prostatic Neoplasms, Castration-Resistant; Spectrometry, Fluorescence | 2020 |
Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; DNA; Drug Design; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutathione; Humans; Mice; Mice, Nude; Molecular Dynamics Simulation; Nucleic Acid Conformation; Oxaliplatin; Platinum; Triazoles | 2021 |
Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
Topics: Cancer Survivors; Cohort Studies; Colonoscopy; Colorectal Neoplasms; Cross-Sectional Studies; Early Detection of Cancer; Humans; Male; Middle Aged; Multicenter Studies as Topic; Platinum; Prospective Studies; Survivors; Testicular Neoplasms | 2021 |
Platinum(iv) oxaliplatin-peptide conjugates targeting memHsp70+ phenotype in colorectal cancer cells.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; HCT116 Cells; HSP70 Heat-Shock Proteins; HT29 Cells; Humans; Organoplatinum Compounds; Oxaliplatin; Peptides; Platinum | 2017 |
Panitumumab-Conjugated and Platinum-Cored pH-Sensitive Apoferritin Nanocages for Colorectal Cancer-Targeted Therapy.
Topics: Apoferritins; Colorectal Neoplasms; ErbB Receptors; Humans; Hydrogen-Ion Concentration; Panitumumab; Platinum | 2018 |
Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage.
Topics: Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; CRISPR-Cas Systems; DNA Damage; DNA Repair; DNA Replication; Humans; Oxaliplatin; Platinum; Reactive Oxygen Species; Transcription, Genetic | 2018 |
EGFR and Prion protein promote signaling via FOXO3a-KLF5 resulting in clinical resistance to platinum agents in colorectal cancer.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; Disease Progression; Drug Resistance, Neoplasm; ErbB Receptors; Forkhead Box Protein O3; Humans; Kruppel-Like Transcription Factors; p38 Mitogen-Activated Protein Kinases; Platinum; Prion Proteins; Signal Transduction; Treatment Outcome | 2019 |
Some new anticancer platinum complexes of dithiocarbamate derivatives against human colorectal and pancreatic cell lines.
Topics: Antineoplastic Agents; Cell Line; Cisplatin; Colorectal Neoplasms; Coordination Complexes; Humans; Molecular Docking Simulation; Platinum | 2020 |
Schiff base-nickel, palladium, and platinum complexes derived from N-cyclohexyl hydrazine carbothioamide and 3-hydroxy-4-methoxybenzaldehyde: Selective antiproliferative and proapoptotic effects against colorectal carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Benzaldehydes; Cell Line; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Humans; Hydrazines; Ligands; Molecular Docking Simulation; Nickel; Palladium; Platinum; Protein-Tyrosine Kinases; Schiff Bases; Thioamides | 2019 |
Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse.
Topics: Animals; Apoptosis; Body Weight; Cell Nucleus; Chemoradiotherapy; Cisplatin; Colorectal Neoplasms; Combined Modality Therapy; HCT116 Cells; Humans; Male; Mice; Mice, Nude; Platinum; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Camptothecin; Cell Line, Tumor; Cisplatin; Colorectal Neoplasms; DNA-Binding Proteins; Drug Synergism; Heterocyclic Compounds, 3-Ring; Humans; Inhibitory Concentration 50; Irinotecan; MRE11 Homologue Protein; Mutation; Phthalazines; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Real-Time Polymerase Chain Reaction | 2014 |
trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Crystallography, X-Ray; Cyclohexanes; Diamines; Drug Resistance, Neoplasm; Humans; Isomerism; Molecular Conformation; Organoplatinum Compounds; Oxaliplatin; Platinum; Prodrugs | 2014 |
Methyl 6-Amino-6-deoxy-d-pyranoside-Conjugated Platinum(II) Complexes for Glucose Transporter (GLUT)-Mediated Tumor Targeting: Synthesis, Cytotoxicity, and Cellular Uptake Mechanism.
Topics: Antineoplastic Agents; Carbohydrates; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Drug Design; Glucose Transport Proteins, Facilitative; HT29 Cells; Humans; Platinum; Solubility | 2016 |
Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Disease Models, Animal; Drug Stability; Humans; Mice; Molecular Conformation; Oxidation-Reduction; Platinum; Prodrugs; Solubility; Structure-Activity Relationship; Tissue Distribution; X-Ray Diffraction | 2017 |
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane.
Topics: Antineoplastic Agents; Apoptosis; Cantharidin; Carboplatin; Carcinoma, Hepatocellular; Cell Cycle; Cisplatin; Colorectal Neoplasms; Cyclohexylamines; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Isomerism; Liver Neoplasms; Organoplatinum Compounds; Oxaliplatin; Platinum; Tumor Cells, Cultured | 2006 |
DNA damage induced by novel demethylcantharidin-integrated platinum anticancer complexes.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cantharidin; Cell Line, Tumor; Colorectal Neoplasms; DNA Damage; DNA, Neoplasm; Humans; Platinum | 2007 |
P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Base Pair Mismatch; Cell Cycle; Cisplatin; Colorectal Neoplasms; DNA Adducts; DNA Repair; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mutagenesis; Platinum; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2001 |